Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7817)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2014 (publication date) through Feb 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang Y, Shi ZL, Yang X, Yin ZF. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. World J Gastroenterol 2014; 20(1): 142-147 [PMID: 24415867 DOI: 10.3748/wjg.v20.i1.142] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i1/142.htm |
| Number | Citing Articles |
| 1 |
Hani Alotaibi, Nese Atabey, Kasım Diril, Esra Erdal, Mehmet Ozturk. Hepatocellular Carcinoma. 2016; : 43 doi: 10.1007/978-3-319-34214-6_3
|
| 2 |
C. Meng, T. Liu, Y.W. Liu, L.Z. Zhang, Y.L. Wang. Hepatitis B Virus cccDNA in Hepatocellular Carcinoma Tissue Increases the Risk of Recurrence After Liver Transplantation. Transplantation Proceedings 2019; 51(10): 3364 doi: 10.1016/j.transproceed.2019.04.020
|
| 3 |
Lisa Kojima, Miho Akabane, Matthew Murray, Michael Fruscione, Daiki Soma, Abigail Snyder, John McVey, Daniel J. Firl, Roberto Hernandez-Alejandro, Chandrashekhar A. Kubal, James F. Markmann, Federico N. Aucejo, Koji Tomiyama, Shoko Kimura, Kazunari Sasaki. Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen. Liver Transplantation 2025; 31(3): 344 doi: 10.1097/LVT.0000000000000459
|
| 4 |
Jin Chen, Xue Li, Qi Cheng, Deng Ning, Jie Ma, Zhi‐Ping Zhang, Xiao‐Ping Chen, Li Jiang. Retracted: Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. Journal of Cellular Biochemistry 2018; 119(2): 2368 doi: 10.1002/jcb.26400
|
| 5 |
Kien Pham, Dan Delitto, Chen Liu. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 153 doi: 10.1007/978-3-319-68082-8_9
|
| 6 |
Xiaoqin Chi, Zhenyu Yin, Jianbin Jin, Hui Li, Jian Zhou, Zhenghuan Zhao, Sheng Zhang, Wenxiu Zhao, Chengrong Xie, Jie Li, Min Feng, Hongyu Lin, Xiaomin Wang, Jinhao Gao. Arsenite-loaded nanoparticles inhibit the invasion and metastasis of a hepatocellular carcinoma:in vitroandin vivostudy. Nanotechnology 2017; 28(44): 445101 doi: 10.1088/1361-6528/aa8791
|
| 7 |
Liu-Jie Gao, Ting-Ting Shao, Wan-Zhen Zheng, Ji-Yuan Ding, Jun Li. Downregulated miR-100 Result in High Expression Levels of Chemokine (CXC Motif) Receptor 7 That Predict Recurrence of Lung Cancer. Journal of Biomaterials and Tissue Engineering 2023; 13(3): 468 doi: 10.1166/jbt.2023.2619
|
| 8 |
Dongdong Yu, Lidong Wang, Tianchun Wu, Yaohui Zhang, Yang Tian, Yan Wang, Chenwei Cui, Hui Li, Jinhua Zhang, Lin Zhou, Sheng Yan, Shusen Zheng. Graft‐Versus‐Tumor Effect in Major Histocompatibility Complex–Mismatched Mouse Liver Transplantation. Liver Transplantation 2019; 25(8): 1251 doi: 10.1002/lt.25574
|
| 9 |
Hui-Ying Liu, Hai-Hua Qian, Xiao-Feng Zhang, Jun Li, Xia Yang, Bin Sun, Jun-Yong Ma, Lei Chen, Zheng-Feng Yin. Improved method increases sensitivity for circulating hepatocellular carcinoma cells. World Journal of Gastroenterology 2015; 21(10): 2918-2925 doi: 10.3748/wjg.v21.i10.2918
|
| 10 |
A. Kornberg, U. Witt, J. Kornberg, H. Friess, K. Thrum. Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation. Alimentary Pharmacology & Therapeutics 2015; 42(9): 1101 doi: 10.1111/apt.13380
|
| 11 |
Guoming Deng, Yufeng Luo, Yaoming Zhang, Jinfeng Zhang, Zongyun He. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway. Bioengineered 2022; 13(2): 2194 doi: 10.1080/21655979.2021.2023983
|
| 12 |
Arno Kornberg, Ulrike Witt, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma. Biomarkers 2016; 21(2): 152 doi: 10.3109/1354750X.2015.1118548
|
| 13 |
Yu Zhang, Xiaofeng Zhang, Jinling Zhang, Bin Sun, Lulu Zheng, Jun Li, Sixiu Liu, Guodong Sui, Zhengfeng Yin. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay. Cancer Biology & Therapy 2016; 17(11): 1177 doi: 10.1080/15384047.2016.1235665
|
| 14 |
Noriko Yamada, Rie Matsushima‑Nishiwaki, Ayaka Masue, Kyoka Taguchi, Osamu Kozawa. Olive oil polyphenols suppress the TGF‑α‑induced migration of hepatocellular carcinoma cells. Biomedical Reports 2019; doi: 10.3892/br.2019.1215
|
| 15 |
Ao Huang, De-Zhen Guo, Xuan Zhang, Ying Sun, Shi-Yu Zhang, Xin Zhang, Xiu-Tao Fu, Yu-Peng Wang, Guo-Huan Yang, Qi-Man Sun, Yi-Feng He, Kang Song, Xiao-Wu Huang, Xin-Rong Yang, Wei-Ren Liu, Zhen-Bin Ding, Ying-Hong Shi, Jia Fan, Jian Zhou. Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer. Hepatology International 2024; 18(1): 254 doi: 10.1007/s12072-023-10594-x
|
| 16 |
Jenny Abrahamsson, Malin Sternby Eilard, Magnus Rizell, William Bennett, Fredrik Åberg. Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation. Scandinavian Journal of Gastroenterology 2022; 57(3): 325 doi: 10.1080/00365521.2021.2010799
|
| 17 |
Kyuho Lee, Kyoung-Bun Lee, Nam-Joon Yi, Kyung-Suk Suh, Ja-June Jang. Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy. Journal of Pathology and Translational Medicine 2017; 51(1): 79 doi: 10.4132/jptm.2016.10.13
|
| 18 |
Qi Ling, Jimin Liu, Jianyong Zhuo, Runzhou Zhuang, Haitao Huang, Xiangxiang He, Xiao Xu, Shusen Zheng. Development of models to predict early post-transplant recurrence of hepatocellular carcinoma that also integrate the quality and characteristics of the liver graft: A national registry study in China. Surgery 2018; 164(1): 155 doi: 10.1016/j.surg.2018.01.022
|
| 19 |
Rie Matsushima-Nishiwaki, Hidenori Toyoda, Tomoaki Nagasawa, Eisuke Yasuda, Naokazu Chiba, Seiji Okuda, Atsuyuki Maeda, Yuji Kaneoka, Takashi Kumada, Osamu Kozawa, Xin-Yuan Guan. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells. PLOS ONE 2016; 11(4): e0151907 doi: 10.1371/journal.pone.0151907
|
| 20 |
Zhong Wang, Lei Luo, Yuan Cheng, Guolin He, Bangjian Peng, Yi Gao, Ze-sheng Jiang, MingXin Pan. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood. Journal of Gastrointestinal Surgery 2018; 22(4): 633 doi: 10.1007/s11605-017-3619-3
|
| 21 |
Zhe Dou, Shuai Lin, Cong Dai, Ye Lu, Tian Tian, Meng Wang, Xinghan Liu, Yi Zheng, Peng Xu, Shanli Li, Qianwen Sheng, Yujiao Deng, Zhijun Dai. Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers. Oncotarget 2017; 8(37): 62703 doi: 10.18632/oncotarget.18697
|
| 22 |
Yawei Zhao, Kan He, Huilin Zheng, Madi Sun, Tongfei Shi, Xiao Zheng, Dan Shao, Hansi Zhang, Fengying Guan, Jing Li, Li Chen. <p>Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; : 5223 doi: 10.2147/OTT.S243357
|
| 23 |
María Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, Víctor Amado-Torres, Rafael Alejandre, Marina Sánchez-Frías, Rubén Ciria, Manuel De la Mata, Manuel Rodríguez-Perálvarez, Gustavo Ferrín. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences 2021; 22(23): 13073 doi: 10.3390/ijms222313073
|
| 24 |
Bin Sun, Congli Hu, Zhibin Yang, Xiaofeng Zhang, Linlin Zhao, Junye Xiong, Junyong Ma, Lei Chen, Haihua Qian, Xiangji Luo, Lehua Shi, Jun Li, Xianshuo Cheng, Zhengfeng Yin. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. Oncotarget 2017; 8(20): 32523 doi: 10.18632/oncotarget.15808
|
| 25 |
A. Kornberg. Letter: prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation – authors' reply. Alimentary Pharmacology & Therapeutics 2016; 43(1): 173 doi: 10.1111/apt.13468
|
| 26 |
Rie Matsushima-Nishiwaki, Hidenori Toyoda, Reika Takamatsu, Eisuke Yasuda, Seiji Okuda, Atsuyuki Maeda, Yuji Kaneoka, Naoki Yoshimi, Takashi Kumada, Osamu Kozawa. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(6): 1629 doi: 10.1016/j.bbadis.2017.04.021
|
| 27 |
Jian Liu, Yongjian Guo, Ruitian Zhang, Ye Xu, Chengju Luo, Rui Wang, Shu Xu, Libin Wei. Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma. Cell Death & Disease 2023; 14(6) doi: 10.1038/s41419-023-05903-z
|
| 28 |
Simone Famularo, Stefano Di Sandro, Alessandro Giani, Andrea Lauterio, Marta Sandini, Riccardo De Carlis, Vincenzo Buscemi, Fabio Uggeri, Fabrizio Romano, Luca Gianotti, Luciano De Carlis. Recurrence Patterns After Anatomic or Parenchyma-Sparing Liver Resection for Hepatocarcinoma in a Western Population of Cirrhotic Patients. Annals of Surgical Oncology 2018; 25(13): 3974 doi: 10.1245/s10434-018-6730-0
|
| 29 |
Miho Akabane, Yuki Imaoka, Jun Kawashima, Austin Schenk, Timothy M. Pawlik. Immunotherapy in liver transplantation for hepatocellular carcinoma: A comprehensive review. Journal of Liver Transplantation 2025; 17: 100256 doi: 10.1016/j.liver.2024.100256
|
| 30 |
|
| 31 |
Yingying Zhang, Tiange Wang, Yinping Zhuang, Tiandi He, Xiaoli Wu, Lin Su, Jun Kang, Jin Chang, Hanjie Wang. Sodium Alginate Hydrogel-Mediated Cancer Immunotherapy for Postoperative In Situ Recurrence and Metastasis. ACS Biomaterials Science & Engineering 2021; 7(12): 5717 doi: 10.1021/acsbiomaterials.1c01216
|
| 32 |
Maurizio Romano, Francesco De Francesco, Giuseppe Pirozzi, Enrico Gringeri, Riccardo Boetto, Marina Di Domenico, Barbara Zavan, Giuseppe A. Ferraro, Umberto Cillo. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma. Oncoscience 2015; 2(5): 443 doi: 10.18632/oncoscience.163
|
| 33 |
Rammohan Devulapally, Kira Foygel, Thillai V Sekar, Juergen K. Willmann, Ramasamy Paulmurugan. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA–PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. ACS Applied Materials & Interfaces 2016; 8(49): 33412 doi: 10.1021/acsami.6b08153
|
| 34 |
Rie Matsushima-Nishiwaki, Noriko Yamada, Yuria Hattori, Yui Hosokawa, Junko Tachi, Takamitsu Hori, Osamu Kozawa, Salvatore V. Pizzo. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. PLOS ONE 2022; 17(1): e0262485 doi: 10.1371/journal.pone.0262485
|
| 35 |
Noriko Yamada, Rie Matsushima-Nishiwaki, Osamu Kozawa. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway. Archives of Biochemistry and Biophysics 2020; 682: 108296 doi: 10.1016/j.abb.2020.108296
|
| 36 |
Minghe Wang, Xuejing Wang, Yanqi Wang, Yikuo Gai, Jingran Ye, Xinyan Xu, Xue You. Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14674
|
| 37 |
Dawei Chen, Shuanghai Liu, Sheng Chen, Zhaowen Wang, Zehua Wu, Kai Ma, Junwei Fan, Zhihai Peng. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation. International Journal of Clinical Oncology 2016; 21(6): 1111 doi: 10.1007/s10147-016-1001-1
|
| 38 |
P. Ramirez, L. Sáenz, P.A. Cascales-Campos, M.R. González Sánchez, E. Llàcer-Millán, M.I. Sánchez-Lorencio, E. Díaz-Rubio, V. De La Orden, B. Mediero-Valeros, J.L. Navarro, B. Revilla Nuin, A. Baroja-Mazo, J.A. Noguera-Velasco, B.F. Sánchez, J. de la Peña, J.A. Pons-Miñano, F. Sánchez-Bueno, R. Robles-Campos, P. Parrilla. Oncological Evaluation by Positron-emission Tomography, Circulating Tumor Cells and Alpha Fetoprotein in Patients With Hepatocellular Carcinoma on the Waiting List for Liver Transplantation. Transplantation Proceedings 2016; 48(9): 2962 doi: 10.1016/j.transproceed.2016.07.035
|
| 39 |
CHANGHE ZHANG, XIAOFEI CAO, YONGXIANG GEI, YONG WANG, GUIYUAN LIU, GUOCHANG CHENG, QINGHONG LIU. Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells. Oncology Letters 2015; 10(3): 1627 doi: 10.3892/ol.2015.3451
|
| 40 |
Adam S. Bodzin, Keri E. Lunsford, Daniela Markovic, Michael P. Harlander-Locke, Ronald W. Busuttil, Vatche G. Agopian. Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation. Annals of Surgery 2017; 266(1): 118 doi: 10.1097/SLA.0000000000001894
|
| 41 |
Arno Kornberg, Ulrike Witt, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients. Digestive Diseases and Sciences 2015; 60(9): 2832 doi: 10.1007/s10620-015-3541-z
|
| 42 |
Qing Ji, Wenhai Wang, Yunquan Luo, Feifei Cai, Yiyu Lu, Wanli Deng, Qi Li, Shibing Su. Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome. Oncotarget 2017; 8(61): 103223 doi: 10.18632/oncotarget.21735
|
| 43 |
Mei Zhang, Wujun Li, Liang Yu, Shengli Wu, Aditya Bhushan Pant. The Suppressive Effect of Resveratrol on HIF-1α and VEGF Expression after Warm Ischemia and Reperfusion in Rat Liver. PLoS ONE 2014; 9(10): e109589 doi: 10.1371/journal.pone.0109589
|
| 44 |
Wenjuan Cai, Zhenglu Wang, Chunfang Wei, Meng Wu, Weiping Zheng, Haiming Zhang, Chenghu Liu, Lei Liu. Prognostic evaluation of NANOG and OCT4 expression for posttransplantation hepatocellular carcinoma recurrence. Journal of Cellular Biochemistry 2019; 120(5): 8419 doi: 10.1002/jcb.28128
|
| 45 |
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World Journal of Gastroenterology 2015; 21(42): 12071-12082 doi: 10.3748/wjg.v21.i42.12071
|
| 46 |
Xiaoyu Wang, Yuanzhi Lao, Naihan Xu, Zhichao Xi, Man Wu, Hua Wang, Xiyi Li, Hongsheng Tan, Menghong Sun, Hongxi Xu. Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins. Scientific Reports 2015; 5(1) doi: 10.1038/srep10293
|
| 47 |
Hsueh-Chou Lai, Chun-Chieh Yeh, Long-Bin Jeng, Shang-Fen Huang, Pei-Ying Liao, Fu-Ju Lei, Wei-Chun Cheng, Cheng-Lung Hsu, Xiujun Cai, Chawnshang Chang, Wen-Lung Ma. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells. Oncotarget 2016; 7(29): 46448 doi: 10.18632/oncotarget.10186
|
| 48 |
Guangjun Shi, Chuanxu Wang, Ping Zhang, Lisha Ji, Shifeng Xu, Xueying Tan, Hao Li. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Archives of Medical Research 2017; 48(6): 553 doi: 10.1016/j.arcmed.2017.11.011
|
| 49 |
Chu Qin, Ru-Yi Huang, Zhao-Xia Wang. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy. Tumor Biology 2015; 36(3): 1403 doi: 10.1007/s13277-015-3267-8
|
| 50 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma. Journal of Surgical Oncology 2019; 120(7): 1126 doi: 10.1002/jso.25721
|
| 51 |
Feng Xue, Shaojun Shi, Zhenzhen Zhang, Cheng Xu, Jianxin Zheng, Tian Qin, Zhiyu Qian, Xiaoyu Zhao, Ying Tong, Lei Xia, Qiang Xia. Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation. Oncology Letters 2018; doi: 10.3892/ol.2018.8019
|
| 52 |
Rie Matsushima-Nishiwaki, Noriko Yamada, Kouki Fukuchi, Osamu Kozawa, Lauren Ashley Cowart. Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2. PLOS ONE 2018; 13(12): e0209050 doi: 10.1371/journal.pone.0209050
|